Last reviewed · How we verify

NCT07488351

"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"

Not yet recruiting Last updated 23 March 2026
What this trial tests

trial testing Self-Report Questionnaire Assessment in Parkinson Disease, Symptom Severity, Functional Status, Quality of Life, Self-compassion, and Self-efficacy in 100 participants. Not yet recruiting.

Timeline
30 March 2026
Primary endpoint
30 December 2026
30 March 2027

Quick facts

Lead sponsorAcibadem University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date30 March 2026
Primary completion30 December 2026
Estimated completion30 March 2027

Drugs / interventions tested

Conditions studied

Sponsor

Acibadem University

Who can join

Adults 40 to 85, any sex, with Parkinson Disease, Symptom Severity, Functional Status, Quality of Life, Self-compassion, and Self-efficacy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Self-Report Questionnaire Assessment

Trials testing the same drug.

Other Acibadem University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07488351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing